Pietro Putignano

1.1k total citations
25 papers, 864 citations indexed

About

Pietro Putignano is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Pharmacology. According to data from OpenAlex, Pietro Putignano has authored 25 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in Pietro Putignano's work include Berberine and alkaloids research (6 papers), Pituitary Gland Disorders and Treatments (5 papers) and Stress Responses and Cortisol (3 papers). Pietro Putignano is often cited by papers focused on Berberine and alkaloids research (6 papers), Pituitary Gland Disorders and Treatments (5 papers) and Stress Responses and Cortisol (3 papers). Pietro Putignano collaborates with scholars based in Italy, Bahrain and Netherlands. Pietro Putignano's co-authors include Francesco Cavagnini, Cecilia Invitti, A. Dubini, Paola Maria Toja, Salvatore Maria Corsello, Francesca Pecori Giraldi, Francesco Di Pierro, Marco Losa, G. Redaelli and Marina Croci and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Molecules.

In The Last Decade

Pietro Putignano

24 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pietro Putignano Italy 16 477 151 136 134 118 25 864
Ludmila Filaretova Russia 18 236 0.5× 299 2.0× 279 2.1× 161 1.2× 122 1.0× 86 898
Takahisa Ushiroyama Japan 20 211 0.4× 120 0.8× 74 0.5× 123 0.9× 69 0.6× 89 1.1k
Panayiotis D. Tsitouras United States 21 946 2.0× 71 0.5× 107 0.8× 210 1.6× 224 1.9× 40 1.7k
William E. Schutzer United States 18 185 0.4× 45 0.3× 102 0.8× 199 1.5× 105 0.9× 28 948
Ioannis Karamouzis Italy 16 497 1.0× 150 1.0× 116 0.9× 157 1.2× 33 0.3× 38 883
M Cacciari Italy 9 357 0.7× 44 0.3× 97 0.7× 217 1.6× 76 0.6× 28 1.0k
Anna M. D'souza Canada 12 284 0.6× 126 0.8× 84 0.6× 376 2.8× 33 0.3× 15 826
Rosaria De Iasio Italy 13 374 0.8× 104 0.7× 43 0.3× 209 1.6× 97 0.8× 22 956
Hans‐Dieter Faulhaber Germany 16 223 0.5× 70 0.5× 89 0.7× 115 0.9× 35 0.3× 29 881
Rita Berardelli Italy 16 601 1.3× 210 1.4× 169 1.2× 87 0.6× 18 0.2× 27 855

Countries citing papers authored by Pietro Putignano

Since Specialization
Citations

This map shows the geographic impact of Pietro Putignano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pietro Putignano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pietro Putignano more than expected).

Fields of papers citing papers by Pietro Putignano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pietro Putignano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pietro Putignano. The network helps show where Pietro Putignano may publish in the future.

Co-authorship network of co-authors of Pietro Putignano

This figure shows the co-authorship network connecting the top 25 collaborators of Pietro Putignano. A scholar is included among the top collaborators of Pietro Putignano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pietro Putignano. Pietro Putignano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Putignano, Pietro, Mattia Garancini, Andrea Gatti, et al.. (2022). An Indeterminate for Malignancy FNA Report Does Not Increase the Surgical Risk of Incidental Thyroid Carcinoma. Cancers. 14(21). 5427–5427. 2 indexed citations
7.
Putignano, Pietro, et al.. (2016). Retrospective analysis of the effects of a highly standardized mixture of Berberis aristata, Silybum marianum, and monacolins K and KA in patients with dyslipidemia. SHILAP Revista de lepidopterología. 6 indexed citations
8.
Pierro, Francesco Di, et al.. (2016). Retrospective analysis of the effects of a highly standardized mixture of <em>Berberis aristata</em>, <em>Silybum marianum</em>, and monacolins K and KA in patients with dyslipidemia. Clinical Pharmacology Advances and Applications. Volume 9. 1–7. 5 indexed citations
9.
Pierro, Francesco Di, et al.. (2015). Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins. Diabetes Metabolic Syndrome and Obesity. 8. 89–89. 38 indexed citations
10.
Pierro, Francesco Di, Pietro Putignano, Luca Montesi, et al.. (2013). Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. Clinical Pharmacology Advances and Applications. 5. 167–167. 59 indexed citations
11.
Orio, Francesco, Giovanna Muscogiuri, Stefano Palomba, et al.. (2013). Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity. IRIS UNIMORE (University of Modena and Reggio Emilia). 8(5). e200–e204. 16 indexed citations
12.
Derosa, Giuseppe, Pietro Putignano, Antonio Bossi, et al.. (2011). Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients. European Journal of Pharmacology. 666(1-3). 251–256. 61 indexed citations
13.
Lancioni, Giulio E., Nirbhay N. Singh, Mark F. O’Reilly, et al.. (2008). Fostering locomotor behavior of children with developmental disabilities: An overview of studies using treadmills and walkers with microswitches. Research in Developmental Disabilities. 30(2). 308–322. 29 indexed citations
14.
Putignano, Pietro, F. Pecori Giraldi, & Francesco Cavagnini. (2004). Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 and pathogenesis of the metabolic syndrome. Journal of Endocrinological Investigation. 27(10). 969–974. 16 indexed citations
15.
Putignano, Pietro, et al.. (2003). Screening for Cushing’s syndrome in obese women with and without polycystic ovary syndrome. Journal of Endocrinological Investigation. 26(6). 539–544. 27 indexed citations
16.
Putignano, Pietro, et al.. (2003). Effect of small doses of dexamethasone on plasma leptin levels in normal and obese subjects: A dose-response study. Journal of Endocrinological Investigation. 26(2). 111–116. 9 indexed citations
17.
Putignano, Pietro, Paola Maria Toja, A. Dubini, et al.. (2003). Midnight Salivary Cortisol Versus Urinary Free and Midnight Serum Cortisol as Screening Tests for Cushing’s Syndrome. The Journal of Clinical Endocrinology & Metabolism. 88(9). 4153–4157. 154 indexed citations
18.
Putignano, Pietro, A. Dubini, Paola Maria Toja, et al.. (2001). Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol. European Journal of Endocrinology. 145(2). 165–171. 154 indexed citations
19.
Cavagnini, Francesco, Marina Croci, Pietro Putignano, Maria Letizia Petroni, & Cecilia Invitti. (2000). Glucocorticoids and neuroendocrine function. International Journal of Obesity. 24(S2). S77–S79. 86 indexed citations
20.
Corsello, Salvatore Maria, Cristina Rota, Pietro Putignano, et al.. (1998). Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer. European Journal of Endocrinology. 139(3). 309–313. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026